Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study

Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study

Introduction: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) have recently been proposed as promising biomarkers in different immune-mediated disorders. We evaluated the plasma levels of MMP-9 and MMP-2 and their tissue inhibitors TIMP-1 and TIMP-2 in a patients...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Vincenzo Di Stefano, Chiara Tubiolo, Andrea Gagliardo, Rosalia Lo Presti, Maria Montana, Massimiliano Todisco, Antonino Lupica, Gregorio Caimi, Cristina Tassorelli, Brigida Fierro, Filippo Brighina, Giuseppe Cosentino
Fformat:	Erthygl
Iaith:	English
Cyhoeddwyd:	MDPI AG 2022-10-01
Cyfres:	Brain Sciences
Pynciau:	matrix metalloproteinases anti-AChR antibodies myasthenia gravis neuromuscular junction
Mynediad Ar-lein:	https://www.mdpi.com/2076-3425/12/11/1439

Eitemau Tebyg

Risk factors for postoperative myasthenia gravis in patients with thymoma without myasthenia gravis: A systematic review and meta-analysis
gan: Mingbo Tang, et al.
Cyhoeddwyd: (2023-02-01)

Role of complement in myasthenia gravis
gan: Pyae Phyo San, et al.
Cyhoeddwyd: (2023-10-01)

Inflammation and autoimmune myasthenia gravis
gan: Ruksana Huda
Cyhoeddwyd: (2023-01-01)

New Approaches to Targeting B Cells for Myasthenia Gravis Therapy
gan: Ruksana Huda
Cyhoeddwyd: (2020-02-01)

Myasthenia gravis and acetylcholine receptor antibodies: A clinico immunological correlative study on South Indian patients
gan: Bindu P, et al.
Cyhoeddwyd: (2008-01-01)

Case report: Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: a report of 2 cases
gan: Tianying Ma, et al.
Cyhoeddwyd: (2025-01-01)

Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies
gan: Hans Frykman, et al.
Cyhoeddwyd: (2020-12-01)

Myasthenia gravis with tongue muscle atrophy: A case series
gan: Xue-Lu Zhao, et al.
Cyhoeddwyd: (2024-05-01)

Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis
gan: Tuan Vu, et al.
Cyhoeddwyd: (2023-06-01)

Antigen specific B cells in myasthenia gravis patients
gan: Kazushiro Takata, et al.
Cyhoeddwyd: (2020-04-01)

Case Report: Telitacicept in severe myasthenia gravis: a case study with multiple autoantibodies
gan: Qian Guo, et al.
Cyhoeddwyd: (2023-12-01)

FoxP3− Tr1 Cell in Generalized Myasthenia Gravis and Its Relationship With the Anti-AChR Antibody and Immunomodulatory Cytokines
gan: Huanyu Meng, et al.
Cyhoeddwyd: (2021-12-01)

Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture
gan: Inga Koneczny, et al.
Cyhoeddwyd: (2019-07-01)

The clinical outcome in AChR-positive generalized myasthenia gravis: A retrospective observational study
gan: Pawan T Ojha, et al.
Cyhoeddwyd: (2023-01-01)

Oral Microbiota Profile in a Group of Anti-AChR Antibody–Positive Myasthenia Gravis Patients
gan: Chao Huang, et al.
Cyhoeddwyd: (2022-07-01)

Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows
gan: Claudia Vinciguerra, et al.
Cyhoeddwyd: (2023-09-01)

Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study
gan: Marco Ceccanti, et al.
Cyhoeddwyd: (2022-08-01)

Long-Term Efficacy of Non-steroid Immunosuppressive Agents in Anti-Muscle-Specific Kinase Positive Myasthenia Gravis Patients: A Prospective Study
gan: Ying Tan, et al.
Cyhoeddwyd: (2022-06-01)

CHARACTERIZATION OF MYASTHENIA GRAVIS USING CLINICAL CLASSIFICATION AND REPETITIVE NERVE STIMULATION
gan: Tho Kieu Anh PHAM, et al.
Cyhoeddwyd: (2021-06-01)

Antibodies to autoantigen targets in myasthenia and their value in clinical practice
gan: S. I. Dedaev
Cyhoeddwyd: (2015-02-01)

New treatment options for generalized myasthenia gravis
gan: Antanas Vaitkus, et al.
Cyhoeddwyd: (2024-02-01)

IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
gan: E. D. Gasymly
Cyhoeddwyd: (2018-06-01)

Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort
gan: Antonino Lupica, et al.
Cyhoeddwyd: (2022-04-01)

Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
gan: Courtney Townsel, et al.
Cyhoeddwyd: (2016-03-01)

Pregnancy with Myasthenia Gravis
gan: Ninuk Dwi ariningtyas, et al.
Cyhoeddwyd: (2020-01-01)

Delayed diagnosis of distal myasthenia gravis: a case report
gan: M. L. Cao, et al.
Cyhoeddwyd: (2024-11-01)

Fetal Surveillance in Pregnancies with Myasthenia Gravis
gan: Brîndușa Ana Cimpoca-Raptis, et al.
Cyhoeddwyd: (2021-11-01)

Pediatric ocular myasthenia gravis: Case report and literature review
gan: Adriana Solano, et al.
Cyhoeddwyd: (2019-01-01)

Disease severity assessment and short-term outcome in patients with myasthenia gravis
gan: Deepthi Vemuri, et al.
Cyhoeddwyd: (2020-01-01)

Myasthenia Gravis in a Patient with HIV
gan: Singh YN, et al.
Cyhoeddwyd: (2009-04-01)

The miracle of St. Alfege’s Hospital and the history of the treatment of myasthenia gravis
gan: Cristina Croitoru, et al.
Cyhoeddwyd: (2017-03-01)

Management of Juvenile Myasthenia Gravis
gan: Karen O'Connell, et al.
Cyhoeddwyd: (2020-07-01)

Myasthenia gravis and related disorders : 11th International Conference /
gan: Kaminski, Henry J., et al.
Cyhoeddwyd: (2008)

Thymectomy in 19 Cases of Myasthenia Gravis in 4 Years Follow up
gan: Saeed Mahmoudi, et al.
Cyhoeddwyd: (2002-09-01)

Positive experience of the usage of Rituximab in management of refractory myasthenia gravis in Russia
gan: N. I. Shcherbakova, et al.
Cyhoeddwyd: (2015-09-01)

Myasthenia gravis in children: analysis of 18 patients
gan: Morita Maria da Penha A., et al.
Cyhoeddwyd: (2001-01-01)

Congenital and Juvenile Myasthenia Gravis
gan: J Gordon Millichap
Cyhoeddwyd: (1996-08-01)

Maintenance Therapy for Myasthenia Gravis
gan: J Gordon Millichap, et al.
Cyhoeddwyd: (2014-07-01)

Ocular myasthenia gravis and thymoma
gan: Victor Alegre-Ituarte, et al.
Cyhoeddwyd: (2022-09-01)

Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis
gan: Cao, M
Cyhoeddwyd: (2021)